The evolutionary path to extraintestinal pathogenic, drug-resistant Escherichia coli is marked by drastic reduction in detectable recombination within the core genome

Genome Biology and Evolution

Volumn 5, Issue 4, 2013, Pages 699-710

  McNally, Alan ^a   Cheng, Lu ^b   Harris, Simon R ^c   Corander, Jukka ^b  

^a NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF HELSINKI   (Finland)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

Diversity; E. coli; Population; Recombination

Indexed keywords

ESCHERICHIA COLI;

EID: 84876585874     PISSN: None     EISSN: 17596653     Source Type: Journal    
DOI: 10.1093/gbe/evt038     Document Type: Article

References (49)

1. Avasthi TS, et al. 2011. Genome of multidrug-resistant uropathogenic Escherichia coli strain NA114 from India. J Bacteriol. 193:4272-4273.
2. Bono JL, et al. 2012. Phylogeny of shiga toxin-producing Escherichia coli O157 isolated from cattle and clinically ill humans. Mol Biol Evol. 29: 2047-2062.
3. Clark G, et al. 2012. Genomic and molecular epidemiology analysis of clinical Escherichia coli ST131 isolates suggests circulation of a genetically monomorphic but phenotypically heterogeneous ExPEC clone. J Antimicrob Chemother. 67:868-877.
4. Clermont O, Bonacorsi S, Bingen E. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol. 66: 4555-4558.
5. Corander J, Connor TR, O'Dwyer CA, Kroll JS, Hanage WP. 2012. Population structure in the Neisseria, and the biological significance of fuzzy species. J R Soc Interface. 9:1208-1215.
6. Corander J,Marttinen P. 2006. Bayesian identification of admixture events using multi-locus molecular markers. Mol Ecol. 15:2833-2843.
7. Corander J, Marttinen P, Sirén J, Tang J. 2008. Enhanced Bayesian modelling in BAPS software for learning genetic structures of populations. BMC Bioinformatics 16:539.
8. Croxall G, et al. 2011. Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains with increased antimicrobial resistance in both community and hospital care settings. J Antimicrob Chemother. 66:2501-2508.
9. Croxen M, Finlay B. 2010. Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol. 8:26-38.
10. Didelot X,Meric G, Falush D, Darling AE. 2012. Impact of homologous and non-homologous recombination in the genomic evolution of Escherichia coli. BMC Genomics 13:256.
11. Dobrindt U, Hochhut B, Hentschel U, Hacker J. 2004. Genomic islands in pathogenic and environmental microorganisms. Nat Rev Microbiol. 2: 414-424.
12. Dykhuizen DE, Green L. 1991. Recombination in Escherichia coli and the definition of biological species. J Bacteriol. 173:7257-7268.
13. Ender PT, et al. 2009. Transmission of an extended-spectrum-beta- lactamase- producing Escherichia coli (sequence type ST131) strain between a father and daughter resulting in septic shock and emphysematous pyelonephritis. J Clin Microbiol. 47:3780-3782.
14. Ewers C, et al. 2010. Emergence of human pandemic O25:H4-ST131 CTXM- 15 extended-spectrum-beta-lactamase-producing Escherichia coli among companion animals. J Antimicrob Chemother. 65:651-660.
15. Foxman B. 2010. The epidemiology of urinary tract infection. Nat Rev Urol. 7:653-660.
16. Hanage WP, Fraser C, Tang J, Connor T, Corander J. 2009. Hyper-recombination, diversity and antibiotic resistance in the pneumococcus. Science 324:1454-1457.
17. Holt KE, et al. 2012. Shigella sonnei genome sequencing and phylogenetic analysis indicate recent global dissemination from Europe. Nat Genet. 44:1056-1059.
18. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. 2010. Escherichia coli type ST131 as the major cause of serious multidrugresistant Escherichia coli infections in the United States. Clin Infect Dis. 51:286-294.
19. Johnson JR, Porter SB, Zhanel G, Kuskowski MA, Denamur E. 2012. Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype. Infect Immun. 80:1554-1562.
20. Kaper JB, Nataro JP,Mobley HL. 2004. Pathogenic Escherichia coli. NatRev Microbiol. 2:123-140.
21. Lau SH, et al. 2008. UK epidemic Escherichia coli strains A-E, with CTX-M- 15 b-lactamase, all belong to the international O25:H4-ST131 clone. J Antimicrob Chemother. 62:1241-1244.
22. Leopold SR, et al. 2009. A precise reconstruction of the emergence and constrained radiations of Escherichia coli O157 portrayed by backbone concatenomic analysis. Proc Natl Acad Sci U S A. 106: 8713-8718.
23. Lloyd AL, Henderson TA, Vigil PD, Mobley HLT. 2009. Genomic islands of uropathogenic Escherichia coli contribute to virulence. J Bacteriol. 191: 3469-3481.
24. Lloyd AL, Rasko DA, Mobley HLT. 2007. Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli. J Bacteriol. 189:3532-3546.
25. Lukjancenko O, Wassenaar TM, Ussery DW. 2010. Comparison of 61 sequenced Escherichia coli genomes. Microb Ecol. 60:708-720.
26. Marttinen P, et al. 2012. Detection of recombination events in bacterial genomes from large population samples. Nucleic Acid Res. 40:e6.
27. Naylor SW, et al. 2003. Lymphoid follicle-dense mucosa at the terminal rectum is the principal site of colonization of enterohemorrhagic Escherichia coli O157:H7 in the bovine host. Infect Immun. 71: 1505-1512.
28. Nicolas-Chanoine M, et al. 2008. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother. 61:273-281.
29. Olesen B, et al. 2012. Enteroaggregative Escherichia coli O78:H10-the cause of an outbreak of urinary tract infection. J Clin Microbiol. 50: 3703-3711.
30. Peirano G, Pitout JDD. 2010. Molecular epidemiology of Escherichia coli producing CTX-M b-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents. 35:316-321.
31. Pitout JDD, Campbell L, Church DL, Gregson DB, Laupland KB. 2009. Molecular characteristics of travel-related extended-spectrum-b-lactamase- producing Escherichia coli isolates from the Calgary health region. Antimicrob Agents Chemother. 53:2539-2543.
32. Platell JL, et al. 2011. Commonality among fluoroquinolone-resistant sequence type ST131 extraintestinal Escherichia coli isolates from humans and companion animals in Australia. Antimicrob Agents Chemother. 8:3782-3787.
33. Platell JL, Johnson JR, Cobbold RN, Trott DJ. 2011. Multidrug-resistant extraintestinal pathogenic Escherichia coli of sequence type ST131 in animals and foods. Vet Microbiol. 153:99-108.
34. Price MN, Dehal PS, Arkin AP. 2009. FastTree: computing large minimum evolution trees with profiles instead of a distancematrix.Mol Biol Evol. 26:1641-1650.
35. Rasko DA, et al. 2008. The pangenome structure of Escherichia coli: comparative genomic analysis of Escherichia coli commensal and pathogenic isolates. J Bacteriol. 190:6881-6893.
36. Rasko DA, et al. 2011. Origins of the Escherichia coli strain causing an outbreak of hemolytic-uremic syndrome in Germany. New Engl JMed. 365:709-717.
37. Rogers BA, Sidjabat HE, Paterson DL. 2011. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother. 66:1-14.
38. Rooney PJ, et al. 2009. Nursing homes as a reservoir of extended-spectrum b-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli. J Antimicrob Chemother. 64:635-641.
39. Sahl JW, et al. 2011. Genomic comparison of multi-drug resistant invasive and colonizing Acinetobacter baumannii isolated from diverse human body sites reveals genomic plasticity. BMC Genomics 12: 291.
40. Schloss PD, et al. 2009. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol. 75:7537-7541.
41. Stamatakis A, Ludwig T, Meier H. 2005. RAxML-III: a fast program for maximum likelihood-based inference of large phylogenetic trees. Bioinformatics 21:456.
42. Tang J, Hanage WP, Fraser C, Corander J. 2009. Identifying currents in the gene pool for bacterial populations using an integrative approach. PLoS Comp Biol. 5:e1000455.
43. Toh H, et al. 2010. Complete genome sequence of the wild-type commensal Escherichia coli Strain SE15, belonging to phylogenetic group B2. J Bacteriol. 192:1165-1166.
44. Totsika M, et al. 2011. Insights into a multidrug-resistant Escherichia coli pathogen of the globally disseminated ST131 lineage: genome analysis and virulence mechanisms. PLoS One 6:e26578.
45. Touchon M, et al. 2009. Organised genome dynamics in the Escherichia coli species results in highly diverse adaptive paths. PLoS Genet. 5: e1000344.
46. Vincent C, et al. 2010. Food reservoir for Escherichia coli causing urinary tract infections. Emerg Infect Dis. 16:88-95.
47. Willems RJ, et al. 2012. Restricted gene flow among hospital subpopulations of Enterococcus faecium. MBio 3:e00151-12.
48. Wirth T, et al. 2006. Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol. 60:1136-1151.
49. Zong Z, Yu R. 2011. blaCTX-M-carrying Escherichia coli of the O25b ST131 clonal group have emerged in China. Diagn Microbiol Infect Dis. 69: 228-231.